glow stack ghk-cu (BPC-157/TB-500/GHK-Cu) — IVs in the Keys glow peptide blend composition ghk-cu
Description
Novo Nordisk filed the New Drug Application (NDA) for CagriSema in early 2026, based on positive results from the REDEFINE phase 3 trial program
GHK-Cu vs retinol Retinol : Increases cell turnover Can be irritating Requires sun protection Proven anti-aging effects Works quickly (weeks) GHK-Cu : Promotes tissue remodeling Very gentle No photosensitivity Excellent safety profile Works gradually (months) Winner : Depends on skin sensitivity
It does not affect blood sugar or cause growth-related side effects
6 patches
Physical Form: Lyophilised powder
